Stay updated with breaking news from Cardiovascular Revascularization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A novel drug-eluting coronary artery implant that “uncages” after 6 months appears to have similar short-term performance to a drug-eluting stent while maintaining flexibility of the treated artery, according to an early study in humans. A single-arm study of 20 patients who received the novel implant (DynamX drug-eluting bioadaptor, Elixir Medical) was published in Cardiovascular
Among patients who develop the complication after complex PCI, nearly one in three die in the hospital.
Disabilities were underreported in clinical trial data and commonly used as a basis for exclusion from trial participation in an analysis of 80 recent trials involving cardiovascular outcomes, according to a study being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.
Patients with Takotsubo cardiomyopathy (TCM), which is typically due to a neurocardiogenic mechanism, with migraine have lower odds of mortality and acute complications compared with TCM patients without migraine.